The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
The Proinflammatory Effect of Prostaglandin E2 in Experimental Inflammatory Bowel Disease Is Mediated through the IL-23→IL-17 Axis
Abstract
Although Crohn’s disease has been traditionally considered to be Th1-mediated, the newly identified Th17 cells emerged recently as crucial participants. Th1/Th17 differentiation is controlled primarily by the IL-12 family of cytokines secreted by activated dendritic cells (DCs) and macrophages. IL-23 and IL-12/IL-27 have opposite effects, supporting the Th17 and Th1 phenotypes, respectively. We found that PGE2, a major lipid mediator released in inflammatory conditions, shifts the IL-12/IL-23 balance in DCs in favor of IL-23, and propose that high levels of PGE2 exacerbate the inflammatory process in inflammatory bowel disease through the IL-23→IL-17 axis. We assessed the effects of PGE2 on IL-12, IL-27, and IL-23 and found that PGE2 promotes IL-23, inhibits IL-12 and IL-27 expression and release from stimulated DCs, and subsequently induces IL-17 production in activated T cells. The effects of PGE2 are mediated through the EP2/EP4 receptors on DCs. In vivo, we assessed the effects of PGE analogs in an experimental model for inflammatory bowel disease and found that the exacerbation of clinical symptoms and histopathology correlated with an increase in IL-23 and IL-17, a decrease in IL-12p35 expression in colon and mesenteric lymph nodes, and a substantial increase in the number of infiltrating neutrophils and of CD4+IL-17+ T cells in the colonic tissue. These studies suggest that high levels of PGE2 exacerbate the inflammatory process through the preferential expression and release of DC-derived IL-23 and the subsequent support of the autoreactive/inflammatory Th17 phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030896 · Cited by 1,669
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00324-2 · Cited by 1,462
The IL-23/IL-17 axis in inflammation
Iwakura, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28508 · Cited by 1,046
Sutton, C., Brereton, C., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,010
Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities
Hanauer, S. B. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000195385.19268.68 · Cited by 968
Stumhofer, J. S., Laurence, A., Wilson, E. H., Huang, E., Tato, C. M., Johnson, L. M., Villarino, A. V., Huang, Q., Yoshimura, A., Sehy, D., et al. (2006) · Nature Immunology · doi:10.1038/ni1376 · Cited by 955
The IL-12 Family of Heterodimeric Cytokines
Trinchieri, G., Pflanz, S., & Kastelein, R. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00296-6 · Cited by 922
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
Hunter, C. A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1648 · Cited by 852
Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., Lee, J., de Sauvage, F. J., & Ghilardi, N. (2006) · Nature Immunology · doi:10.1038/ni1375 · Cited by 825
Interleukin-23 drives innate and T cell–mediated intestinal inflammation
Hue, S., Ahern, P., Buonocore, S., Kullberg, M. C., Cua, D. J., McKenzie, B. S., Powrie, F., & Maloy, K. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061099 · Cited by 823
Understanding the IL-23–IL-17 immune pathway
McKenzie, B. S., Kastelein, R. A., & Cua, D. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.10.003 · Cited by 766
Differential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune Pathology
Uhlig, H. H., McKenzie, B. S., Hue, S., Thompson, C., Joyce-Shaikh, B., Stepankova, R., Robinson, N., Buonocore, S., Tlaskalova-Hogenova, H., Cua, D. J., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.05.017 · Cited by 682
The role of Th1/Th2 polarization in mucosal immunity
Neurath, M. F., Finotto, S., & Glimcher, L. H. (2002) · Nature Medicine · doi:10.1038/nm0602-567 · Cited by 623
Expanding the effector CD4 T-cell repertoire: the Th17 lineage
Harrington, L. E., Mangan, P. R., & Weaver, C. T. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.017 · Cited by 590
IL-23 plays a key role in Helicobacter hepaticus –induced T cell–dependent colitis
Kullberg, M. C., Jankovic, D., Feng, C. G., Hue, S., Gorelick, P. L., McKenzie, B. S., Cua, D. J., Powrie, F., Cheever, A. W., Maloy, K. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061082 · Cited by 590
Chen, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25308 · Cited by 555
Takeda, A., Hamano, S., Yamanaka, A., Hanada, T., Ishibashi, T., Mak, T. W., Yoshimura, A., & Yoshida, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4886 · Cited by 530
Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y., & Narumiya, S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701367 · Cited by 510
Shanahan, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07284-7 · Cited by 478
Critical role of IL-17 receptor signaling in acute TNBS-induced colitis
Zhang, Z., Zheng, M., Bindas, J., Schwarzenberger, P., & Kolls, J. K. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000218764.06959.91 · Cited by 465
The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.
Lubberts, E., Koenders, M. I., & van den Berg, W. B. (2005) · Arthritis Research · doi:10.1186/ar1478 · Cited by 438
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214459 · Cited by 418
Role of Toll-like Receptors in Spontaneous Commensal-Dependent Colitis
Rakoff-Nahoum, S., Hao, L., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.010 · Cited by 344
Fuss, I. J., Becker, C., Yang, Z., Groden, C., Hornung, R. L., Heller, F., Neurath, M. F., Strober, W., & Mannon, P. J. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000194183.92671.b6 · Cited by 326
Cruz, A., Khader, S. A., Torrado, E., Fraga, A., Pearl, J. E., Pedrosa, J., Cooper, A. M., & Castro, A. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1416 · Cited by 288
Schmidt, C., Giese, T., Ludwig, B., Mueller-Molaian, I., Marth, T., Zeuzem, S., Meuer, S. C., & Stallmach, A. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200501000-00003 · Cited by 280
Morteau, O., Morham, S. G., Sellon, R., Dieleman, L. A., Langenbach, R., Smithies, O., & Sartor, R. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci6899 · Cited by 275
T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17
Rangachari, M., Mauermann, N., Marty, R. R., Dirnhofer, S., Kurrer, M. O., Komnenovic, V., Penninger, J. M., & Eriksson, U. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052222 · Cited by 264
Divergent effects of IL‐12 and IL‐23 on the production of IL‐17 by human T cells
Hoeve, M. A., Savage, N. D. L., de Boer, T., Langenberg, D. M. L., de Waal Malefyt, R., Ottenhoff, T. H. M., & Verreck, F. A. W. (2006) · European Journal of Immunology · doi:10.1002/eji.200535239 · Cited by 245
Upregulation of Interleukin-12 and -17 in Active Inflammatory Bowel Disease
Nielsen, O. H., Kirman, I., Rüdiger, N., Hendel, J., & Vainer, B. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310000672 · Cited by 240
Cutting Edge: IL-23 Cross-Regulates IL-12 Production in T Cell-Dependent Experimental Colitis
Becker, C., Dornhoff, H., Neufert, C., Fantini, M. C., Wirtz, S., Huebner, S., Nikolaev, A., Lehr, H.-A., Murphy, A. J., Valenzuela, D. M., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2760 · Cited by 227
Cohn, S. M., Schloemann, S., Tessner, T., Seibert, K., & Stenson, W. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119296 · Cited by 224
Defects in mucosal immunity leading to Crohn's disease
Cobrin, G. M., & Abreu, M. T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00293.x · Cited by 208
Neurath, M., Fuss, I., & Strober, W. (2000) · International Reviews of Immunology · doi:10.3109/08830180009048389 · Cited by 191
Prostaglandin E2 induces IL‐23 production in bone marrow‐derived dendritic cells
Sheibanie, A. F., Tadmori, I., Jing, H., Vassiliou, E., & Ganea, D. (2004) · The FASEB Journal · doi:10.1096/fj.03-1367fje · Cited by 171
Self-citationPositive and Negative Regulation of the IL-27 Receptor during Lymphoid Cell Activation
Villarino, A. V., Larkin, J., Saris, C. J. M., Caton, A. J., Lucas, S., Wong, T., de Sauvage, F. J., & Hunter, C. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7684 · Cited by 166
McKaig, B. C., Hughes, K. R., Tighe, P. J., & Mahida, Y. R. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00048.2001 · Cited by 155
T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype
Mathur, A. N., Chang, H.-C., Zisoulis, D. G., Kapur, R., Belladonna, M. L., Kansas, G. S., & Kaplan, M. H. (2006) · Blood · doi:10.1182/blood-2006-04-015016 · Cited by 143
Tessner, T. G., Cohn, S. M., Schloemann, S. R., & Stenson, W. F. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70259-8 · Cited by 138
Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells
Vassiliou, E. K., Jing, H., & Ganea, D. (2003) · Cellular Immunology · doi:10.1016/s0008-8749(03)00158-8 · Cited by 132
Self-citationProstaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells
Jing, H., Vassiliou, E. K., & Ganea, D. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303116 · Cited by 114
Self-citationCortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease
González‐Rey, E., Varela, N., Sheibanie, A. F., Chorny, A., Ganea, D., & Delgado, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508997103 · Cited by 111
Self-citationColonic lamina propria dendritic cells in mice with CD4+ T cell‐induced colitis
Krajina, T., Leithäuser, F., Möller, P., Trobonjača, Z., & Reimann, J. (2003) · European Journal of Immunology · doi:10.1002/eji.200323518 · Cited by 111
Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn?s disease
Stallmach, A., Giese, T., Schmidt, C., Ludwig, B., Mueller-Molaian, I., & Meuer, S. C. (2004) · International Journal of Colorectal Disease · doi:10.1007/s00384-003-0554-4 · Cited by 111
Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum
Thiéfin, G., & Beaugerie, L. (2004) · Joint Bone Spine · doi:10.1016/j.jbspin.2004.10.004 · Cited by 107
New mediators of immunity and inflammation in inflammatory bowel disease
Monteleone, G., Fina, D., Caruso, R., & Pallone, F. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000231808.10773.8e · Cited by 106
Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27
Beadling, C., & Slifka, M. K. (2006) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-006-0002-6 · Cited by 102
Beltinger, J., McKaig, B. C., Makh, S., Stack, W. A., Hawkey, C. J., & Mahida, Y. R. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.2.c271 · Cited by 100
IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland
Limbergen, J. V., Russell, R. K., Nimmo, E. R., Drummond, H. E., Smith, L. A., Davies, G., Anderson, N., Gillett, P. M., McGrogan, P., Hassan, K., et al. (2007) · Gut · doi:10.1136/gut.2007.122069 · Cited by 93
Jiang, G.-L., Nieves, A. L., Im, W. B., Old, D. W., Dinh, D. D., & Wheeler, L. A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111146 · Cited by 88
Ballinger, M. N., Aronoff, D. M., McMillan, T. R., Cooke, K. R., Olkiewicz, K. M., Toews, G. B., Peters-Golden, M. L., & Moore, B. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5499 · Cited by 87
Relapse of Inflammatory Bowel Disease Associated With Use of Nonsteroidal Anti-Inflammatory Drugs
Meyer, A. M., Ramzan, N. N., Heigh, R. I., & Leighton, J. A. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-3103-5 · Cited by 71
Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy
Bowman, E. P., Chackerian, A. A., & Cua, D. J. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000224818.42729.67 · Cited by 59
Effects of a COX-2 Preferential Agent Nimesulide on TNBS-Induced Acute Inflammation in the Gut
Kankuri, E. M., Vaali, K., Korpela, R., Paakkari, I., Vapaatalo, H., & Moilanen, E. (2001) · Inflammation · doi:10.1023/a:1012860509440 · Cited by 47
Mast cells are not essential to inflammation in murine model of colitis
Chin, K. W., & Barrett, K. E. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02088336 · Cited by 37
Targeting Cytokines of the Interleukin-12 Family in Autoimmunity
Kang, B., & Kim, T. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776360879 · Cited by 35
Induction of Immunity and Inflammation by Interleukin-12 Family Members
Alber, G., Al‐Robaiy, S., Kleinschek, M. A., Knauer, J., Krumbholz, P., Richter, J., Schoeneberger, S., Schütze, N., Schulz, S. M., Toepfer, K., et al. (2006) · Springer eBooks · doi:10.1007/3-540-37673-9_7 · Cited by 34
Zhang, Z., Andoh, A., Inatomi, O., Bamba, S., Takayanagi, A., Shimizu, N., & Fujiyama, Y. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03748.x · Cited by 32
Zhang, L., Yu Min, L. U., & Xiu Yun, D. O. N. G. (2004) · Chinese Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2004.00164.x · Cited by 27
Cited by
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Regulation of Immune Responses by Prostaglandin E2
Kalinski, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101029 · Cited by 1,474
The role of COX‐2 in intestinal inflammation and colorectal cancer
Wang, D., & DuBois, R. N. (2010) · Oncogene · doi:10.1038/onc.2009.421 · Cited by 805
Evidence for a cross-talk between human neutrophils and Th17 cells
Pelletier, M., Maggi, L., Micheletti, A., Lazzeri, E., Tamassia, N., Costantini, C., Cosmi, L., Lunardi, C., Annunziato, F., Romagnani, S., et al. (2010) · Blood · doi:10.1182/blood-2009-04-216085 · Cited by 782
Metadata
- Authors
- Sheibanie, A. F., Yen, J.-H., Khayrullina, T., Emig, F., Zhang, M., Tuma, R., & Ganea, D.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06
- Volume
- 178
- Issue
- 12
- Pages
- 8138-8147
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1940681873
- Cited by
- 284
- References
- 70
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.